A shortage of ANY medicine which patients require for survival is a concern. It is similar to persistent drug shortages of essential medicines because they have become commoditized. While @costplusdrugs.com is addressing some episodically, government policy to eliminate shortages is needed.

Show Post

I am far less confident than Novo's chief counsel that their patent will not be invalidated. Recent actions by FDA/HHS/DOJ are much more likely to protect the company's prized asset #Wegovy.

Show Post

Btw, Merck is using the PTAB, a mechanism to review wrongly-granted patents, to challenge Halozyme’s patents. Ironically, PhRMA, where Merck is a long-standing member, is lobbying to pass the PREVAIL Act to gut that very mechanism.

Show Post

Show Post

The only valuable thing being sold and consumed here is our attention.

Show Post